Health Product Shortages homepage

Welcome to Health Product Shortages Canada, the website for mandatory reporting of health product shortages and discontinuations by regulated parties. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the health products they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca (opens in new window).

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

List of shortage reports
Brand name Company Name Status Strength Update Date Updated View Report
APO-NAPROXEN EC TABLETS APOTEX INC Actual shortage 250MG New Report 2026-04-17 283172
APO-ATOMOXETINE APOTEX INC Actual shortage 40MG Updated Report 2026-04-17 280271
APO-ATOMOXETINE APOTEX INC Actual shortage 40MG Updated Report 2026-04-17 280268
ZYMAR ABBVIE CORPORATION Actual shortage 0.3% Updated Report 2026-04-17 271370
OCUFLOX ABBVIE CORPORATION Actual shortage 0.3% Updated Report 2026-04-17 265046
!!T3 IFEX BAXTER CORPORATION Actual shortage 1G Updated Report 2026-04-17 273126
!!T3 IFEX BAXTER CORPORATION Actual shortage 3G Updated Report 2026-04-17 273129
ESTRADOT 75 SANDOZ CANADA INCORPORATED Anticipated shortage 75MCG New Report 2026-04-17 283153
ESTRADOT 25 SANDOZ CANADA INCORPORATED Anticipated shortage 25MCG New Report 2026-04-17 283150
ESTRADOT 100 SANDOZ CANADA INCORPORATED Actual shortage 100MCG Updated Report 2026-04-17 279263

Discontinuation Reports

List of discontinuation reports
Brand name Company Name Status Strength Update Date Updated View Report
TRYPTAN BAUSCH HEALTH, CANADA INC. To be discontinued 750MG New Report 2026-04-16 283097
TRYPTAN BAUSCH HEALTH, CANADA INC. To be discontinued 1G New Report 2026-04-16 283051
CANCIDAS MERCK CANADA INC Discontinued 50MG Updated Report 2026-04-15 273084
SYNPHASIC 21 TABLETS PFIZER CANADA ULC Discontinued 1.0MG 0.035MG 0.035MG 0.5MG Updated Report 2026-04-15 270053
SANDOZ RISPERIDONE SANDOZ CANADA INCORPORATED Discontinued 4MG New Report 2026-04-15 282918
Get it on Google Play Download on the App Store